David Johnson
Director/Board Member bij CARIBOU BIOSCIENCES, INC.
Vermogen: - $ op 31-03-2024
Profiel
David L.
Johnson is currently an Independent Director at Caribou Biosciences, Inc. He previously worked as the Vice President-Sales & Marketing at Gilead Sciences, Inc. from 2003 to 2018 and as the Chief Commercial Officer at Global Blood Therapeutics, Inc. from 2018 to 2022.
Mr. Johnson completed his undergraduate degree at the University of Puget Sound and holds an MBA from Kenan-Flagler Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-02-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van David Johnson
| Bedrijven | Functie | Begin |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 11-05-2022 |
Eerdere bekende functies van David Johnson
| Bedrijven | Functie | Einde |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2022 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01-01-2018 |
Opleiding van David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
